Rotundine b
CAS No. 483-14-7
Rotundine b( L-Tetrahydropalmatine | (-)-Tetrahydropalmatine | Caseanine | Gindarine )
Catalog No. M19458 CAS No. 483-14-7
Rotundine (L-tetrahydropalmatine L-THP) is a selective dopamine D1 receptor antagonist with IC50 of 166 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 29 | In Stock |
|
| 100MG | 41 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 91 | In Stock |
|
| 1G | 138 | In Stock |
|
Biological Information
-
Product NameRotundine b
-
NoteResearch use only, not for human use.
-
Brief DescriptionRotundine (L-tetrahydropalmatine L-THP) is a selective dopamine D1 receptor antagonist with IC50 of 166 nM.
-
DescriptionRotundine (L-tetrahydropalmatine L-THP) is a selective dopamine D1 receptor antagonist with IC50 of 166 nM.(In Vivo):It is reported that Rotundine (l-THP) possesses a blocking effect on dopamine D1 and D2 receptors and can inhibit physical dependence in morphine dependent mice and significantly reduce the development of the conditional place preference induced by morphine in mice. On day 1 and 7, there is no difference in locomotor counts between the Rotundine groups (6.25, 12.5, and 18.75 mg/kg) and saline group [F(3, 37)=1.360, P>0.05, F(3, 37)=0.348, P>0.05, respectively]. Locomotor counts are greatly increased in the oxycodone group compare with the saline group. Rotundine at doses of 6.25, 12.5, and 18.75 mg/kg antagonizes hyperactivity induced by oxycodone [F(4, 60)=15.76, P<0.01]. Rotundine (6.25, 12.5 mg/kg) does not affect the magnitude of sensitization, but there is a marked difference between oxycodone+oxycodone group and Rotundine (18.75 mg/kg)+oxycodone+oxycodone group, indicating that Rotundine (18.75 mg/kg) greatly inhibits the development of oxycodone sensitization [F(4, 62)=8.766, P<0.01].
-
In Vitro——
-
In VivoIt is reported that Rotundine (l-THP) possesses a blocking effect on dopamine D1 and D2 receptors and can inhibit physical dependence in morphine dependent mice and significantly reduce the development of the conditional place preference induced by morphine in mice. On day 1 and 7, there is no difference in locomotor counts between the Rotundine groups (6.25, 12.5, and 18.75 mg/kg) and saline group [F(3, 37)=1.360, P>0.05, F(3, 37)=0.348, P>0.05, respectively]. Locomotor counts are greatly increased in the oxycodone group compare with the saline group. Rotundine at doses of 6.25, 12.5, and 18.75 mg/kg antagonizes hyperactivity induced by oxycodone [F(4, 60)=15.76, P<0.01]. Rotundine (6.25, 12.5 mg/kg) does not affect the magnitude of sensitization, but there is a marked difference between oxycodone+oxycodone group and Rotundine (18.75 mg/kg)+oxycodone+oxycodone group, indicating that Rotundine (18.75 mg/kg) greatly inhibits the development of oxycodone sensitization [F(4, 62)=8.766, P<0.01].
-
SynonymsL-Tetrahydropalmatine | (-)-Tetrahydropalmatine | Caseanine | Gindarine
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorD1 receptor 5-HT1A D2 receptor D3 receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number483-14-7
-
Formula Weight355.43
-
Molecular FormulaC21H25NO4
-
Purity>98% (HPLC)
-
SolubilityDMSO:8 mg/mL (22.5 mM);Ethanol:<1 mg/mL;Water:<1 mg/mL
-
SMILES[H][C@@]12CC3=CC=C(OC)C(OC)=C3CN1CCC1=C2C=C(OC)C(OC)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
A-381393
A-381393 is a selective and brain penetrate dopamine D4 receptor antagonist (Kis: 1.9/1.5/1.6 nM for human dopamine D4.2/D4.4/D4.7 receptor).
-
SKF-83566
SKF-83566 is a blood-brain permeable and orally active antagonist of D1-like dopamine receptor and a weaker competitive 5-HT2 receptor antagonist with Ki of 11 nMSKF-83566 caused a concentration-dependent increase in peak single-pulse evoked extracellular DA concentration, with a maximum increase of 65% in 5 μM SKF-83566.?
-
Pericyazine
Pericyazine is a selective D2-dopamine receptor antagonist. Pericyazine is a first-generation antipsychotic drug that is used as an adjunct to the short-term management of severe anxiety states and psychosis.
Cart
sales@molnova.com